20 (AIDX) Other Non Operating Income (2025 - 2026)
20 (AIDX) posted Other Non Operating Income of -$148766.0 for Q1 2026, down 129261.74% on a QoQ basis from -$115.0 in Q1 2025, and down 129261.74% year-over-year from N/an in Q1 2025.
20 (AIDX) Other Non Operating Income (2025 - 2026) Analysis & Trends
20's Other Non Operating Income history runs 2 years deep, the most recent figure standing at -$148766.0 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn |
| 10 | 20 | 3.53 Mn | -692,945.03 | 62,884.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -148,766.00 |
| Mar 31, 2025 | -115.00 |